{"id":"https://openalex.org/W1897292152","doi":"https://doi.org/10.1002/cncr.29728","title":"Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinoma","display_name":"Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinoma","publication_year":2015,"publication_date":"2015-10-06","ids":{"openalex":"https://openalex.org/W1897292152","doi":"https://doi.org/10.1002/cncr.29728","mag":"1897292152","pmid":"https://pubmed.ncbi.nlm.nih.gov/26439451","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4602387"},"language":"en","primary_location":{"id":"doi:10.1002/cncr.29728","doi":"https://doi.org/10.1002/cncr.29728","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.29728","pdf_url":"https://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.29728","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.29728","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109602066","display_name":"Sekwon Jang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800468613","display_name":"Inova Fairfax Hospital","ror":"https://ror.org/0212h5y77","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I116530498","https://openalex.org/I2800468613"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sekwon Jang","raw_affiliation_strings":["Division of Oncology, Inova Dwight and Martha Schar Cancer Institute, Fairfax, Virginia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Inova Dwight and Martha Schar Cancer Institute, Fairfax, Virginia","institution_ids":["https://openalex.org/I2800468613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102008184","display_name":"Chaoyi Zheng","orcid":"https://orcid.org/0000-0003-1688-7585","observed_orcids":["https://orcid.org/0000-0003-1688-7585"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chaoyi Zheng","raw_affiliation_strings":["Department of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center; Georgetown University; Washington DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center; Georgetown University; Washington DC","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100908231","display_name":"Huei\u2010Ting Tsai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Huei\u2010Ting Tsai","raw_affiliation_strings":["Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC;","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075257656","display_name":"Alex Z. Fu","orcid":"https://orcid.org/0000-0002-4020-6519","observed_orcids":["https://orcid.org/0000-0002-4020-6519"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Z. Fu","raw_affiliation_strings":["Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC;","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031050771","display_name":"Ana Barac","orcid":"https://orcid.org/0000-0002-9935-8904","observed_orcids":["https://orcid.org/0000-0002-9935-8904"]},"institutions":[{"id":"https://openalex.org/I1285739803","display_name":"MedStar Washington Hospital Center","ror":"https://ror.org/05ry42w04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285739803","https://openalex.org/I86755215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ana Barac","raw_affiliation_strings":["Division of Cardiology, Medstar Washington Hospital Center, Washington DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiology, Medstar Washington Hospital Center, Washington DC","institution_ids":["https://openalex.org/I1285739803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052526230","display_name":"Michael B. Atkins","orcid":"https://orcid.org/0000-0003-3901-9924","observed_orcids":["https://orcid.org/0000-0003-3901-9924"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael B. Atkins","raw_affiliation_strings":["Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC;","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102853284","display_name":"Andrew N. Freedman","orcid":"https://orcid.org/0000-0003-1451-4208","observed_orcids":["https://orcid.org/0000-0003-1451-4208"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew N. Freedman","raw_affiliation_strings":["Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037416583","display_name":"Lori M. Minasian","orcid":"https://orcid.org/0000-0002-0472-4079","observed_orcids":["https://orcid.org/0000-0002-0472-4079"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lori Minasian","raw_affiliation_strings":["Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046800754","display_name":"Arnold L. Potosky","orcid":"https://orcid.org/0000-0001-8087-6667","observed_orcids":["https://orcid.org/0000-0001-8087-6667"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arnold L. Potosky","raw_affiliation_strings":["Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC;","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5109602066"],"corresponding_institution_ids":["https://openalex.org/I2800468613"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":2.9836,"has_fulltext":true,"cited_by_count":47,"citation_normalized_percentile":{"value":0.91790274,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"122","issue":"1","first_page":"124","last_page":"130"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.8140000104904175,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.8140000104904175,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.1412000060081482,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.012799999676644802,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.6949999928474426},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.8339999914169312},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.9169999957084656},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.8600000143051147},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":1.0},{"id":"https://openalex.org/keywords/vegfr-tyrosine-kinase-inhibitors","display_name":"VEGFR inhibitors","score":0.9490000009536743},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.6029999852180481},{"id":"https://openalex.org/keywords/congestive-heart-failure","display_name":"congestive heart failure","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cardiomyopathy","display_name":"cardiomyopathy","score":0.9710000157356262},{"id":"https://openalex.org/keywords/acute-myocardial-infarction","display_name":"acute myocardial infarction","score":0.9739999771118164},{"id":"https://openalex.org/keywords/adverse-cardiovascular-events","display_name":"cardiovascular adverse events","score":0.8259999752044678},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.8939999938011169},{"id":"https://openalex.org/keywords/advanced-renal-cell-carcinoma","display_name":"advanced renal cell carcinoma","score":0.8040000200271606}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9551215767860413},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.7654553651809692},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6493271589279175},{"id":"https://openalex.org/C2992356464","wikidata":"https://www.wikidata.org/wiki/Q574834","display_name":"Antiangiogenic therapy","level":3,"score":0.5764453411102295},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4999113082885742},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48993057012557983},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2945367097854614}],"mesh":[{"descriptor_ui":"D000077157","descriptor_name":"Sorafenib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077210","descriptor_name":"Sunitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018426","descriptor_name":"SEER Program","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/cncr.29728","doi":"https://doi.org/10.1002/cncr.29728","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.29728","pdf_url":"https://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.29728","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:26439451","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26439451","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4602387","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4602387","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1002/cncr.29728","doi":"https://doi.org/10.1002/cncr.29728","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.29728","pdf_url":"https://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.29728","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G1989789713","display_name":"Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS)","funder_award_id":"UL1TR001409","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G2594326790","display_name":null,"funder_award_id":"HHSN261201200362P","funder_id":"https://openalex.org/F4320332505","funder_display_name":"U.S. Public Health Service"},{"id":"https://openalex.org/G3599785481","display_name":null,"funder_award_id":"HHSN261201200362P","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5986057411","display_name":"Georgetown-Howard Universities Center for Clinical and Translational Science (GHU","funder_award_id":"KL2TR000102","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G7458456260","display_name":"Institutional Career Development Core","funder_award_id":"KL2TR001432","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000862544","display_name":"Georgetown University Lombardi Comprehensive Cancer Center Support Grant","funder_award_id":"P30CA051008","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332505","display_name":"U.S. Public Health Service","ror":"https://ror.org/05xf94514"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1897292152.pdf","grobid_xml":"https://content.openalex.org/works/W1897292152.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W1963518763","https://openalex.org/W1965024282","https://openalex.org/W1978315939","https://openalex.org/W1993291335","https://openalex.org/W1999966467","https://openalex.org/W2049941544","https://openalex.org/W2056802932","https://openalex.org/W2105641380","https://openalex.org/W2131754429","https://openalex.org/W2149456801","https://openalex.org/W2153362990","https://openalex.org/W2157358083","https://openalex.org/W2164802689","https://openalex.org/W2231156824"],"related_works":["https://openalex.org/W2617691504","https://openalex.org/W4388595642","https://openalex.org/W2944255805","https://openalex.org/W2248910050","https://openalex.org/W1979287092","https://openalex.org/W2947118462","https://openalex.org/W7217596253","https://openalex.org/W3162188159","https://openalex.org/W1907991309","https://openalex.org/W4315646641"],"abstract_inverted_index":{"BACKGROUND:":[0],"Sorafenib":[1],"and":[2,19,56,71,90,98,119,127,156,161,187,251,263],"sunitinib":[3,144],"are":[4],"oral":[5],"vascular":[6],"endothelial":[7],"growth":[8],"factor":[9],"receptor":[10],"(VEGFR)":[11],"tyrosine":[12],"kinase":[13],"inhibitors":[14],"(TKIs)":[15],"approved":[16],"in":[17,45,195],"2005":[18],"2006,":[20],"respectively,":[21],"for":[22,123,153,211],"the":[23,38,53,115,128,234,242],"treatment":[24],"of":[25,37,41,82,130,137,139,177,238,244,260],"patients":[26,48,63,141,199,223],"with":[27,74,173,197,201,241,256],"renal":[28],"cell":[29],"carcinoma":[30],"(RCC).":[31],"A":[32,106,135],"population-based,":[33],"observational":[34],"cohort":[35],"study":[36,61],"cardiovascular":[39,83,99,148,178,261],"risk":[40,176,237,259],"VEGFR":[42],"TKI":[43],"therapy":[44],"elderly":[46],"RCC":[47,75,203],"was":[49,101,111,171],"conducted.":[50],"METHODS:":[51],"Using":[52],"Surveillance,":[54],"Epidemiology,":[55],"End":[57],"Results-Medicare":[58],"database,":[59],"this":[60],"analyzed":[62],"who":[64,142,208,224],"were":[65,72,121,158,209,225],"66":[66,226],"years":[67,229],"old":[68,230],"or":[69,145,168,246],"older":[70],"diagnosed":[73,200],"from":[76,204],"2000":[77],"to":[78,113,206,227],"2009.":[79],"The":[80,150],"incidence":[81,151],"adverse":[84],"events,":[85],"including":[86],"congestive":[87],"heart":[88],"failure":[89],"cardiomyopathy":[91],"(CHF/CM),":[92],"acute":[93],"myocardial":[94],"infarction":[95],"(AMI),":[96],"stroke,":[97],"deaths,":[100],"examined":[102],"through":[103],"December":[104],"2010.":[105],"Cox":[107],"proportional":[108],"hazards":[109],"model":[110],"created":[112],"calculate":[114],"hazard":[116],"ratio":[117],"(HR),":[118],"adjustments":[120],"made":[122],"age,":[124],"sex,":[125],"comorbidity,":[126],"use":[129,170,243],"other":[131],"systemic":[132],"therapy.":[133],"RESULTS:":[134],"total":[136],"171":[138],"670":[140],"received":[143],"sorafenib":[146,169,252],"had":[147,233],"events.":[149],"rates":[152],"CHF/CM,":[154],"AMI,":[155],"stroke":[157,189,239],"0.87,":[159],"0.14,":[160],"0.14":[162],"per":[163],"1000":[164],"person-days,":[165],"respectively.":[166],"Sunitinib":[167,250],"associated":[172,240,255],"an":[174,257],"increased":[175,236,258],"events":[179,262],"(HR,":[180,190],"1.38;":[181],"95%":[182,192],"confidence":[183],"interval":[184],"[CI],":[185],"1.02-1.87)":[186],"especially":[188],"2.84;":[191],"CI,":[193],"1.52-5.31)":[194],"comparison":[196],"788":[198],"advanced":[202],"2007":[205],"2009":[207],"eligible":[210],"Part":[212],"D":[213],"but":[214],"did":[215],"not":[216],"receive":[217],"either":[218,245],"agent.":[219],"In":[220],"subgroup":[221],"analyses,":[222],"74":[228],"at":[231],"diagnosis":[232],"highest":[235],"both":[247],"drugs.":[248],"CONCLUSIONS:":[249],"might":[253],"be":[254],"particularly":[264],"stroke.":[265]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}